E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/12/2006 in the Prospect News Biotech Daily.

American BioMedica regains Nasdaq compliance

By Lisa Kerner

Charlotte, N.C., June 12 - The Nasdaq Stock Market has notified American BioMedica Corp. that its stock had a closing bid of $1.00 or greater per share for at least 10 consecutive business days. As a result, the company is once again in compliance with Nasdaq requirements for continued listing.

In March, American BioMedica was notified that its stock had closed below the minimum $1.00 per share requirement for 30 consecutive business days.

Located in Kinderhook, N.Y., American BioMedica is a biomedical company that develops diagnostic test kits.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.